연구동향 분석

Development and Testing of Thrombolytics in Stroke

Dmitri Nikitin Seungbum Choi Jan Mican Martin Toul Wi-Sun Ryu Jiri Damborsky Robert Mikulik Dong-Eog Kim 2021년

논문상세정보
인용/피인용
' Development and Testing of Thrombolytics in Stroke' 의 주제별 논문영향력
논문영향력 선정 방법
논문영향력 요약
주제
  • Protein engineering
  • Stroke
  • Tissue plasminogen activator
  • thrombolytic therapy
동일주제 총논문수 논문피인용 총횟수 주제별 논문영향력의 평균
1,395 0

0.0%

' Development and Testing of Thrombolytics in Stroke' 의 참고문헌

  • tPA-S481A prevents neurotoxicity of endogenous tPA in traumatic brain injury
    Armstead WM [2012]
  • tPA regulates neurite outgrowth by phosphorylation of LRP5/6in neural progenitor cells
    Lee SH [2014]
  • tPA Helpers in the Treatment of Acute Ischemic Stroke: Are They Ready for Clinical Use?
    Jong S. Kim [2019]
  • t-PA-specific modulation of a human blood-brain barrier model involves plasmin-mediated activation of the Rho kinase pathway in astrocytes
    Niego B [2012]
  • Zebrafish model of photochemical thrombosis for translational research and thrombolytic screening in vivo
    Lee IJ [2017]
  • Variants of human tissue-type plasminogen activator that lack specific structural domains of the heavy chain
    Gething MJ [1988]
  • Urokinase plasminogen activator : a potential thrombolytic agent for ischaemic stroke
    Kadir RRA [2020]
  • Urokinase and non-urokinase fibrinolytic activity in protease-inhibitor-deprived plasma, assayed by a fibrin micro-plate method
    Fossum S [1996]
  • Ultrasound-enhanced thrombolytic effect of tissue plasminogen activator-loaded echogenic liposomes in an in vivo rabbit aorta thrombus model-brief report
    Laing ST [2011]
  • Ultrasound-enhanced systemic thrombolysis for acute ischemic stroke
  • Two receptor systems are involved in the plasma clearance of tissue-type plasminogen activator(t-PA)in vivo
    Narita M [1995]
  • Treatment and outcome of hemorrhagic transformation after intravenous alteplase in acute ischemic stroke : a scientific statement for healthcare professionals from the American Heart Association/American Stroke Association
    Yaghi S [2017]
  • Transendothelial migration of ferric ion in FeCl3 injured murine common carotid artery
    Tseng MT [2006]
  • Tissue-type plasminogen activator : a historical perspective and personal account
    Collen D [2004]
  • Tissue plasminogen activator-mediated PDGF signaling and neurovascular coupling in stroke
    Su EJ [2009]
  • Tissue plasminogen activator prevents white matter damage following stroke
    Correa F [2011]
  • Tissue plasminogen activator in the amygdala is critical for stress-induced anxiety-like behavior
    Pawlak R [2003]
  • Tissue plasminogen activator for acute ischemic stroke
  • Tissue plasminogen activator expression is restricted to subsets of excitatory pyramidal glutamatergic neurons
    Louessard M [2016]
  • Tissue plasminogen activator contributes to the late phase of LTP and to synaptic growth in the hippocampal mossy fiber pathway
    Baranes D [1998]
  • Thrombotic distal middle cerebral artery occlusion produced by topical FeCl(3)application : a novel model suitable for intravital microscopy and thrombolysis studies
    Karatas H [2011]
  • Thrombolytic properties of a novel modified human tissue-type plasminogen activator(E6010) : a bolus injection of E6010 has equivalent potency of lysing young and aged canine coronary thrombi
    Suzuki S [1991]
  • Thrombolytic and pharmacokinetic properties of human tissue-type plasminogen activator variants, obtained by deletion and/or duplication of structural/functional domains, in a hamster pulmonary embolism model
    Collen D [1991]
  • Thrombolytic and haemorrhagic effects of bolus doses of tissue-type plasminogen activator and a hybrid plasminogen activator with prolonged plasma half-life(K2tu-PA : CGP 42935)
    Agnelli G [1993]
  • Thrombolysis with saruplase versus streptokinase in acute myocardial infarction : five-year results of the PRIMI trial
    Spiecker M [1999]
  • Thrombolysis with rhPro-UK 3 to 6 hours after embolic stroke in rat
    Hao CH [2019]
  • Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke
    Hacke W [2008]
  • Thrombolysis vs. bleeding from hemostatic sites by a prourokinase mutant compared with tissue plasminogen activator
    Gurewich V [2006]
  • Thromboelastography: a tool for measuring hypercoagulability, hypocoagulability, and fibrinolysis
    Donahue SM [2005]
  • Thrombectomy within 8 hours after symptom onset in ischemic stroke
    Jovin TG [2015]
  • Thrombectomy for stroke at 6 to 16 hours with selection by perfusion imaging
    Albers GW [2018]
  • Therapy for acute ischemic stroke : the door opens : interpreting the NINDS rt-PA stroke study
    Sila CA [1996]
  • The ‘fibrinolytic potential’ as a simple measure of spontaneous fibrinolysis
  • The use of PEGylated liposomes to prolong circulation lifetimes of tissue plasminogen activator
    Kim JY [2009]
  • The urokinase-streptokinase pulmonary embolism trial(phase II)results
    Bell WR [1974]
  • The urokinase plasminogen activator system in cancer : recent advances and implication for prognosis and therapy
    Sidenius N [2003]
  • The tissue-type plasminogen activator story
    Collen D [2009]
  • The structure of the human tissue-type plasminogen activator gene : correlation of intron and exon structures to functional and structural domains
    Ny T [1984]
  • The smallest stroke : occlusion of one penetrating vessel leads to infarction and a cognitive deficit
    Shih AY [2013]
  • The role of plasminogen activators in stroke treatment : fibrinolysis and beyond
    Thiebaut AM [2018]
  • The rapid fibrin plate : a method for plasminogen activator assay
    Marsh NA [1977]
  • The proteolytic activity of tissue-plasminogen activator enhances NMDA receptor-mediated signaling
    Nicole O [2001]
  • The plasminogen activator of vampire bat saliva
  • The plasminogen activator family from the salivary gland of the vampire bat Desmodus rotundus : cloning and expression
  • The importance of size : successful recanalization by intravenous thrombolysis in acute anterior stroke depends on thrombus length
    Riedel CH [2011]
  • The ideal fibrinolytic : can drug design improve clinical results
  • The fibrinolytic activity of hemolytic streptococci
    Tillett WS [1933]
  • The fibrin plate method for estimating fibrinolytic activity
    Astrup T [1952]
  • The effectiveness of activators in clot lysis, with special reference to fibrinolytic therapy: a new method for determination of preformed clot lysis
    Blix S [1962]
  • The desmoteplase in acute ischemic stroke trial(DIAS) : a phase II MRI-based 9-hour window acute stroke thrombolysis trial with intravenous desmoteplase
    Hacke W [2005]
  • The comparison of solid phase and fibrin plate methods for the measurement of plasminogen activators
    Millar WT [1983]
  • The benefits and harms of intravenous thrombolysis with recombinant tissue plasminogen activator within 6 h of acute ischaemic stroke(the third international stroke trial [IST-3]) : a randomised controlled trial
  • Tenecteplase versus alteplase in stroke thrombolysis : an individual patient data meta-analysis of randomized controlled trials
    Huang X [2016]
  • Tenecteplase versus alteplase for management of acute ischaemic stroke (NOR-TEST): a phase 3, randomised, open-label, blinded endpoint trial
    Logallo N [2017]
  • Tenecteplase versus alteplase before thrombectomy for ischemic stroke
  • Tenecteplase versus alteplase before endovascular thrombectomy (EXTEND-IA TNK): a multicenter, randomized, controlled study
    Campbell BC [2018]
  • Tenecteplase knocking on the door
    Hill MD [2018]
  • Tenecteplase in ischemic stroke offers improved recanalization : analysis of 2 trials
    Bivard A [2017]
  • Tenecteplase for the treatment of acute ischemic stroke : a review of completed and ongoing randomized controlled trials
    Coutts SB [2018]
  • Temperature-sensitive liposome-mediated delivery of thrombolytic agents
    Saxena V [2015]
  • Taurine reduces tPA(tissue-type plasminogen activator)-induced hemorrhage and microvascular thrombosis after embolic stroke in rat
    Jin R [2018]
  • Targeted drug delivery to flow-obstructed blood vessels using mechanically activated nanotherapeutics
    Korin N [2015]
  • T2-and diffusion-weighted magnetic resonance imaging of a focal ischemic lesion in rat brain
  • Synthesis, regulation and production of urokinase using mammalian cell culture: a comprehensive review
  • Subacute hemorrhage and resolution of edema in Rose Bengal stroke model in rats coincides with improved sensorimotor functions
    Jolkkonen J [2007]
  • Structure-based antigenic epitope and PEGylation improve the efficacy of staphylokinase
    Xu Y [2017]
  • Structural features mediating fibrin selectivity of vampire bat plasminogen activators
    Bringmann P [1995]
  • Structural biology and protein engineering of thrombolytics
    Mican J [2019]
  • Streptococcus uberis plasminogen activator(SUPA)activates human plasminogen through novel species-specific and fibrin-targeted mechanisms
    Zhang Y [2012]
  • Strategies for the improvement of thrombolytic agents
    Lijnen HR [1991]
  • Stimulation of tissue plasminogen activator by denatured proteins and fibrin clots : a possible additional role for plasminogen activator
    Radcliffe R [1981]
  • Stenotrophomonas maltophilia Gd2 : a potential and novel isolate for fibrinolytic enzyme production
    Khursade PS [2019]
  • Staphylokinase; an activator of plasma protease
    Lack CH [1948]
  • Staphylokinase: a potent, uniquely fibrin-selective thrombolytic agent
    Collen D [1998]
  • Staphylokinase-annexin XI chimera exhibited efficient in vitro thrombolytic activities
    Chiou JF [2007]
  • Spectrophotometric analysis of thrombolytic activity : SATA assay
    Zamanlu M [2018]
  • Sonothrombolysis
    Bader KB [2016]
  • Sonic hedgehog signaling pathway mediates cerebrolysin-improved neurological function after stroke
    Zhang L [2013]
  • Single-cell, high-throughput analysis of cell docking to vessel wall
  • Single and repeated intravenous toxicity studies of pamiteplase(genetical recombination)in rats and monkeys
    Ishikawa A [1997]
  • Simple quantitative measurement based on DWI to objectively judge DWI-FLAIR mismatch in a canine stroke model
    Liu S [2015]
  • Should clot composition affect choice of endovascular therapy
    Mehta BP [2012]
  • Short‐Term Cessation of Dabigatran Causes a Paradoxical Prothrombotic State
    Jiwon Kim [2021]
  • Shear-induced platelet aggregation : 3D-grayscale microfluidics for repeatable and localized occlusive thrombosis
    Griffin MT [2019]
  • Serial changes in cerebral blood flow and flow-metabolism uncoupling in primates with acute thromboembolic stroke
    Kuge Y [2001]
  • Selective middle cerebral artery occlusion in the rabbit : technique and characterization with pathologic findings and multimodal MRI
    Jahan R [2019]
  • Selective liposomal transport through blood brain barrier disruption in ischemic stroke reveals two distinct therapeutic opportunities
  • Scale up and pharmacokinetic study of a novel mutated chimeric tissue plasminogen activator(mt-PA)in rats
    Raigani M [2017]
  • Safety and efficacy of mechanical embolectomy in acute ischemic stroke : results of the MERCI trial
    Smith WS [2005]
  • Safety and efficacy of desmoteplase given 3-9 h after ischaemic stroke in patients with occlusion or high-grade stenosis in major cerebral arteries (DIAS-3): a double-blind, randomised, placebo-controlled phase 3 trial
    Albers GW [2015]
  • Role of NMDA receptor signaling in the regulation of inflammatory gene expression after focal brain ischemia
    Jander S [2000]
  • Review of protocols used in ultrasound thrombolysis
  • Reteplase: structure, function, and production
    Mohammadi E [2019]
  • Resolving the multifaceted mechanisms of the ferric chloride thrombosis model using an interdisciplinary microfluidic approach
  • Regulation of plasminogen activation on cell surfaces and fibrin
    Urano T [2018]
  • Receptor-associated protein(RAP)has two high-affinity binding sites for the low-density lipoprotein receptor-related protein(LRP) : consequences for the chaperone functions of RAP
    Jensen JK [2009]
  • Rat model of arterial thrombosis induced by ferric chloride
    Kurz KD [1990]
  • Randomized assessment of rapid endovascular treatment of ischemic stroke
    Goyal M [2015]
  • Radioactive(I125)human plasma clots for assay of thrombolytic activity
    Hume M [1964]
  • Quantitative imaging of cerebral thromboemboli in vivo : the effects of tissue-type plasminogen activator
    Kim DE [2017]
  • Quantitative dissection of the binding contributions of ligand lysines of the receptor-associated protein(RAP)to the low density lipoprotein receptor-related protein(LRP1)
    Dolmer K [2013]
  • Purification and partial characterization of plasminogen activator from human uterine tissue
    Rijken DC [1979]
  • Purification and characterization of a novel, highly potent fibrinolytic enzyme from Bacillus subtilis DC27 screened from Douchi, a traditional Chinese fermented soybean food
    Hu Y [2019]
  • Progressive and reproducible focal cortical ischemia with or without late spontaneous reperfusion generated by a ring-shaped, laser-driven photothrombotic lesion in rats
    Hu X [2001]
  • Production of monoclonal antibodies to the high fibrin-affinity, tissue-type plasminogen activator of human plasma: demonstration of its endothelial origin by immunolocalization
  • Principles and practice of thromboelastography in clinical coagulation management and transfusion practice
    Bolliger D [2012]
  • Pregnancy zone protein-tissue-type plasminogen activator complexes bind to low-density lipoprotein receptor-related protein(LRP)
    Sánchez MC [2001]
  • Precise characterization of the penumbra revealed by MRI : a modified photothrombotic stroke model study
    Qian C [2016]
  • Polyacrylic acid-coated nanoparticles loaded with recombinant tissue plasminogen activator for the treatment of mice with ischemic stroke
    Huang L [2019]
  • Plasminogen is a critical host pathogenicity factor for group A streptococcal infection
    Sun H [2004]
  • Plasminogen activator inhibitor 1 contains a cryptic high affinity receptor binding site that is exposed upon complex formation with tissue-type plasminogen activator
    Horn IR [1998]
  • Plasma urokinase levels measured by chromogenic assay after infusions of tissue culture or urinary source material
    Barlow GH [1980]
  • Photochemically induced cortical infarction in the rat. 1. Time course of hemodynamic consequences
    Dietrich WD [1986]
  • Perfused 3D angiogenic sprouting in a high-throughput in vitro platform
  • Penta-l-lysine potentiates fibrin-independent activity of human tissue plasminogen activator
    Rehan M [2015]
  • PEGylation of truncated streptokinase leads to formulation of a useful drug with ameliorated attributes
    Sawhney P [2016]
  • Optimized tPA : a non-neurotoxic fibrinolytic agent for the drainage of intracerebral hemorrhages
    Goulay R [2018]
  • Opening the window : ischemic postconditioning reduces the hyperemic response of delayed tissue plasminogen activator and extends its therapeutic time window in an embolic stroke model
  • Novel thrombolytic drug based on thrombin cleavable microplasminogen coupled to a single-chain antibody specific for activated GPIIb/IIIa
    Bonnard T [2017]
  • Novel recombinant thrombolytic and antithrombotic staphylokinase variants with an RGD motif at their N-termini
    He J [2008]
  • Non-invasive induction of focal cerebral ischemia in mice by photothrombosis of cortical microvessels : characterization of inflammatory responses
    Schroeter M [2002]
  • Neuroprotective effects of the spin trap agent disodium-[(tert-butylimino)methyl]benzene-1,3-disulfonate N-oxide (generic NXY-059) in a rabbit small clot embolic stroke model: combination studies with the thrombolytic tissue plasminogen activator
    Lapchak PA [2002]
  • Neuroprotective effect of asiatic acid in rat model of focal embolic stroke
    Lee KY [2014]
  • Neuronal migration is retarded in mice lacking the tissue plasminogen activator gene
    Seeds NW [1999]
  • Nattokinase : a promising alternative in prevention and treatment of cardiovascular diseases
    Chen H [2018]
  • Nanoliposome containing cyclosporine A reduced neuroinflammation responses and improved neurological activities in cerebral ischemia/reperfusion in rat
    Partoazar A [2017]
  • Multiple therapeutic effects of progranulin on experimental acute ischaemic stroke
    Kanazawa M [2015]
  • Mouse model of microembolic stroke and reperfusion
    Atochin DN [2004]
  • Mouse model of in situ thromboembolic stroke and reperfusion
    Orset C [2007]
  • Monocyte-expressed urokinase regulates human vascular smooth muscle cell migration in a coculture model
    Kusch A [2002]
  • Mimicking arterial thrombosis in a 3D-printed microfluidic in vitro vascular model based on computed tomography angiography data
    Costa PF [2017]
  • Microplasmin : a novel thrombolytic that improves behavioral outcome after embolic strokes in rabbits
    Lapchak PA [2002]
  • Microfluidic modeling of thrombolysis : effect of antiplatelet and anticoagulant agents on tPA(tissue-type plasminogen activator)-induced fibrinolysis
    Loyau S [2018]
  • Methods available to assess therapeutic potential of fibrinolytic enzymes of microbial origin : a review
  • Low rates of acute recanalization with intravenous recombinant tissue plasminogen activator in ischemic stroke : real-world experience and a call for action
    Bhatia R [2010]
  • Liposomes for drug delivery in stroke
    Bruch GE [2019]
  • Liposomal nanocarriers for plasminogen activators
    Koudelka S [2016]
  • Laser speckle contrast imaging of cerebral blood flow in freely moving animals
    Miao P [2011]
  • Lack of secondary microthrombosis after thrombin-induced stroke in mice and non-human primates
    Gauberti M [2014]
  • Lab-on-a-chip for the development of pro-/anti-angiogenic nanomedicines to treat brain diseases
  • Kinetics of the activation of plasminogen by human tissue plasminogen activator. Role of fibrin
    Hoylaerts M [1982]
  • Kinetic analysis of the interactions between plasminogen activator inhibitor 1 and both urokinase and tissue plasminogen activator
    Hekman CM [1988]
  • Involvement of finger domain and kringle 2 domain of tissue-type plasminogen activator in fibrin binding and stimulation of activity by fibrin
  • Intrinsic biotaxi solution based on blood cell membrane cloaking enables fullerenol thrombolysis in vivo
    Chen K [2020]
  • Intravenous desmoteplase in patients with acute ischaemic stroke selected by MRI perfusion–diffusion weighted imaging or perfusion CT (DIAS-2): a prospective, randomised, double-blind, placebo-controlled study
    Hacke W [2009]
  • Intracoronary thrombolysis in patients with acute myocardial infarction : comparison of the efficacy of urokinase with streptokinase
    Tennant SN [1984]
  • Interactions between staphylokinase, plasmin(ogen), and fibrin. Staphylokinase discriminates between free plasminogen and plasminogen bound to partially degraded fibrin
    Sakharov DV [1996]
  • Interaction of one-chain and twochain tissue plasminogen activator with intact and plasmin-degraded fibrin
    Higgins DL [1987]
  • Interaction of mutants of tissue-type plasminogen activator with liver cells : effect of domain deletions
    Kuiper J [1996]
  • Inflammatory cell recruitment after experimental thromboembolic stroke in rats
    Lehmann J [2014]
  • Induction of reproducible brain infarction by photochemically initiated thrombosis
    Watson BD [1985]
  • Induction and imaging of photothrombotic stroke in conscious and freely moving rats
    Lu H [2014]
  • In-vitro assessment of the thrombolytic efficacy of therapeutic ultrasound
  • In vivo monitoring of macrophage infiltration in experimental ischemic brain lesions by magnetic resonance imaging
  • In vivo clearance of tissue plasminogen activator : the complex role of sites of glycosylation and level of sialylation
    Cole ES [1993]
  • In vitro thrombolytic activity of a purified fibrinolytic enzyme from Chlorella vulgaris
    Silva PEDCE [2018]
  • In vitro combinations of red blood cell, plasma and platelet components evaluated by thromboelastography
    Agren A [2014]
  • Improving the solubility, activity, and stability of reteplase using in silico design of new variants
    Ghaheh HS [2019]
  • Identification of the mechanism responsible for the increased fibrin specificity of TNK-tissue plasminogen activator relative to tissue plasminogen activator
    Stewart RJ [2000]
  • Identification and characterization of novel tPA-and plasminogen-binding sites within fibrin(ogen)alpha C-domains
    Tsurupa G [2001]
  • Identification and characterization of Harobin, a novel fibrino(geno)lytic serine protease from a sea snake (Lapemis hardwickii)
    He J [2007]
  • Hyperacute direct thrombus imaging using computed tomography and gold nanoparticles
    Kim DE [2013]
  • Human synovial fibroblasts produce urokinase-type plasminogen activator
    Medcalf RL [1986]
  • Histopathologic correlates of abnormal water diffusion in cerebral ischemia : diffusion-weighted MR imaging and light and electron microscopic study
    Pierpaoli C [1993]
  • Heat denaturation of plasminogen in the fibrin plate method
    Lassen M [1953]
  • Global, regional, and national burden of stroke, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016
  • Further characterisation of a thromboembolic model of stroke in the rat
    Beech JS [2001]
  • Focal embolic cerebral ischemia in the rat
    Zhang L [2015]
  • Fluorogenic substrates for sensitive and differential estimation of urokinase and tissue plasminogen activator
  • First structural model of full-length human tissue-plasminogen activator : a SAXS data-based modeling study
    Rathore YS [2012]
  • Fibrinolytic properties of one-chain and two-chain human extrinsic(tissue-type)plasminogen activator
    Rijken DC [1982]
  • Fibrinolytic enzyme production by newly isolated Bacillus cereus SRM001 with enhanced in-vitro blood clot lysis potential
  • Fibrinolytic effects of urokinase and heparin in acute pulmonary embolism : a randomized clinical trial
    Marini C [1988]
  • Fibrinolytic activity of normal urine
  • Fibrinolysis : from blood to the brain
    Medcalf RL [2017]
  • Fibrinogen alpha C domains contain cryptic plasminogen and tPA binding sites
    Tsurupa G [2001]
  • Expression of human plasminogen activator inhibitor type-1 (PAI-1) in Escherichia coli as a soluble protein comprised of active and latent forms. Isolation and crystallization of latent PAI-1
    Franke AE [1990]
  • Expression of a novel chimeric-truncated tPA in Pichia pastoris with improved biochemical properties
  • Expression of a novel chimeric truncated t-PA in CHO cells based on in silico experiments
    Davami F [2010]
  • Exploration of enzyme diversity by integrating bioinformatics with expression analysis and biochemical characterization
    Vanacek P [2018]
  • Experimental thromboembolic stroke in cynomolgus monkey
    Kito G [2001]
  • Experimental and imaging techniques for examining fibrin clot structures in normal and diseased states
    Fan NK [2015]
  • Evolution of photochemically induced focal cerebral ischemia in the rat : magnetic resonance imaging and histology
    Lee VM [1996]
  • Evidence that tenecteplase is noninferior to alteplase for acute ischemic stroke : meta-analysis of 5 randomized trials
    Burgos AM [2019]
  • Evidence for a rapid inhibitor to tissue plasminogen activator in plasma
  • Evaluation of neurovascular function in mouse cortex using multispectral optical imaging after ischemic stroke
    Zhu YQ [2019]
  • Evaluation of a weight-adjusted single-bolus plasminogen activator in patients with myocardial infarction: a double-blind, randomized angiographic trial of lanoteplase versus alteplase
  • Epitope mapping for four monoclonal antibodies against human plasminogen activator inhibitor type-1 : implications for antibody-mediated PAI-1-neutralization and vitronectin-binding
    Wind T [2001]
  • Engineering, expression and purification of a chimeric fibrin-specific streptokinase
    Taheri MN [2016]
  • Engineering of plasminogen activators for targeting to thrombus and heightening thrombolytic efficacy
    Absar S [2015]
  • Engineering of plasmin-resistant forms of streptokinase and their production in Bacillus subtilis : streptokinase with longer functional half-life
    Wu XC [1998]
  • Engineering of deglycosylated and plasmin resistant variants of recombinant streptokinase in Pichia pastoris
    Babbal A [2018]
  • Engineering of Harobin for enhanced fibrinolytic activity obtained by random and site-directed mutagenesis
    Li Z [2017]
  • Engineered staphylokinase variants with reduced immunogenicity
    Collen D [1998]
  • Engineered nanoplatelets for targeted delivery of plasminogen activators to reverse thrombus in multiple mouse thrombosis models
    Xu J [2020]
  • Endothelial cell activation in an embolic ischemia-reperfusion injury microfluidic model
    Amar DN [2019]
  • Embolic middle cerebral artery occlusion(MCAO)for ischemic stroke with homologous blood clots in rats
    Jin R [2014]
  • Embolic middle cerebral artery occlusion model using thrombin and fibrinogen composed clots in rat
    Ren M [2012]
  • Efficacy of urokinase lock to treat thrombotic dysfunction of tunneled hemodialysis catheters : a retrospective cohort study
    Van Hulle F [2019]
  • Efficacy of intra-arterial and intravenous prourokinase in an embolic stroke model evaluated by diffusion-perfusion magnetic resonance imaging
    Takano K [1998]
  • Efficacy of alteplase in a mouse model of acute ischemic stroke : a retrospective pooled analysis
    Orset C [2016]
  • Efficacy of SMTP-7, a small-molecule anti-inflammatory thrombolytic, in embolic stroke in monkeys
    Suzuki E [2018]
  • Effects of thrombolysis within 6 hours on acute cerebral infarction in an improved rat embolic middle cerebral artery occlusion model for ischaemic stroke
    Si Z [2019]
  • Effects of the spin trap agent disodium-[tert-butylimino)methyl]benzene-1,3-disulfonate N-oxide (generic NXY-059)on intracerebral hemorrhage in a rabbit large clot embolic stroke model: combination studies with tissue plasminogen activator
    Lapchak PA [2002]
  • Effect of treatment delay, age, and stroke severity on the effects of intravenous thrombolysis with alteplase for acute ischaemic stroke: a meta-analysis of individual patient data from randomised trials
    Emberson J [2014]
  • Effect of thrombin on the fibrinolytic activity of cultured bovine endothelial cells
  • Early abrogation of gelatinase activity extends the time window for tPA thrombolysis after embolic focal cerebral ischemia in mice
    Chen S [2018]
  • Dynamic changes of magnetic resonance imaging abnormalities in relation to inflammation and glial responses after photothrombotic cerebral infarction in the rat brain
    Schroeter M [2001]
  • Dyed fibrin plate assay of fibrinolysis
    Barta G [1966]
  • Dose-response, therapeutic time-window and tPA-combinatorial efficacy of compound 21: a randomized, blinded preclinical trial in a rat model of thromboembolic stroke
    Ishrat T [2019]
  • Dose escalation of desmoteplase for acute ischemic stroke(DEDAS) : evidence of safety and efficacy 3 to 9hours after stroke onset
    Furlan AJ [2006]
  • Dodecafluoropentane emulsion decreases infarct volume in a rabbit ischemic stroke model
    Culp WC [2012]
  • Displacement of sensory maps and disorganization of motor cortex after targeted stroke in mice
    Harrison TC [2013]
  • Direct thrombus imaging as a means to control the variability of mouse embolic infarct models : the role of optical molecular imaging
    Kim DE [2011]
  • Direct imaging of cerebral thromboemboli using computed tomography and fibrin-targeted gold nanoparticles
    Kim JY [2015]
  • Direct fluorescent assay of urokinase and plasminogen activators of normal and malignant cells : kinetics and inhibitor profiles
    Zimmerman M [1978]
  • Development of an in vitro model to study clot lysis activity of thrombolytic drugs
    Prasad S [2006]
  • Development of a rat model of photothrombotic ischemia and infarction within the caudoputamen
    Kuroiwa T [2009]
  • Development and validation of a high throughput whole blood thrombolysis plate assay
    Bonnard T [2017]
  • Development and application of global assays of hyper-and hypofibrinolysis
    Ilich A [2020]
  • Desmoteplase 3 to 9 hours after major artery occlusion stroke : the DIAS-4 trial(efficacy and safety study of desmoteplase to treat acute ischemic stroke)
  • Design of a novel chimeric tissue plasminogen activator with favorable vampire bat plasminogen activator properties
    Kazemali M [2014]
  • Demonstration of therapeutic window of cerebrolysin in embolic stroke: a prospective, randomized, blinded, and placebo-controlled study
    Zhang L [2017]
  • Decreased thromboembolic stroke but not atherosclerosis or vascular remodelling in mice with ROCK2-deficient platelets
  • Cyclic RGD functionalized liposomes encapsulating urokinase for thrombolysis
    Zhang N [2018]
  • Crystal structure of the catalytic domain of human plasmin complexed with streptokinase
    Wang X [1998]
  • Conversion of fibrinogen to fibrin : mechanism of exposure of tPA-and plasminogen-binding sites
    Yakovlev S [2000]
  • Conservation of critical functional domains in murine plasminogen activator inhibitor-1
    Xu Z [2004]
  • Comparison of saruplase and alteplase in acute myocardial infarction. SESAM Study Group. The Study in Europe with Saruplase and Alteplase in Myocardial Infarction
    Bär FW [1997]
  • Comparison of expression optimization of new derivative of staphylokinase (SAK-2RGDTTI) with the rSAK
    Faraji H [2019]
  • Comparative study of the relative signal intensity on DWI, FLAIR, and T2 images in identifying the onset time of stroke in an embolic canine model
    Xu XQ [2014]
  • Combined treatment with recombinant tissue plasminogen activator and dexamethasone phosphate-containing liposomes improves neurological outcome and restricts lesion progression after embolic stroke in rats
    Tiebosch IA [2012]
  • Combined near-infrared fluorescent imaging and micro-computed tomography for directly visualizing cerebral thromboemboli
    Kim DE [2016]
  • Collaborative angiographic patency trial of recombinant staphylokinase(CAPTORS)
  • Collaborative angiographic patency trial of recombinant staphylokinase(CAPTORS II)
  • Clot lysis by gastric juice : an in vitro study
    Patchett SE [1989]
  • Cloning and expression of human tissue-type plasminogen activator cDNA in E. coli
    Pennica D [1983]
  • Cleavage of proBDNF by tPA/plasmin is essential for longterm hippocampal plasticity
    Pang PT [2004]
  • Characterization of the interactions of plasminogen and tissue and vampire bat plasminogen activators with fibrinogen, fibrin, and the complex of d-Dimer noncovalently linked to fragment E
    Stewart RJ [1998]
  • Characterization of a recombinant chimeric plasminogen activator with enhanced fibrin binding
    Jiao J [2001]
  • Characterization of a novel chronic photothrombotic ring stroke model in rats by magnetic resonance imaging, biochemical imaging, and histology
    Hilger T [2004]
  • Characterization of a new model of thromboembolic stroke in C57black/6J mice
    Ansar S [2014]
  • Cellular catabolism of recombinant tissue-type plasminogen activator. Identification and characterization of a novel high affinity uptake system on rat hepatocytes
    Bakhit C [1987]
  • Cell associated urokinase activity and colonic epithelial cells in health and disease
    Gibson PR [1991]
  • Both compensation and recovery of skilled reaching following small photothrombotic stroke to motor cortex in the rat
    Moon SK [2009]
  • Blocking of platelets or intrinsic coagulation pathway-driven thrombosis does not prevent cerebral infarctions induced by photothrombosis
  • Biochemical determinants of clearance of tissue-type plasminogen activator from the circulation
    Lucore CL [1988]
  • Binding of tissue-type plasminogen activator to lysine, lysine analogues, and fibrin fragments
    de Munk GA [1989]
  • Autonomous functions of structural domains on human tissue-type plasminogen activator
  • Atorvastatin extends the therapeutic window for tPA to 6 h after the onset of embolic stroke in rats
    Zhang L [2009]
  • Association of clinical, imaging, and thrombus characteristics with recanalization of visible intracranial occlusion in patients with acute ischemic stroke
    Menon BK [2018]
  • Assessment of the patient with hyperacute stroke : imaging and therapy
  • Arterial obstruction on computed tomographic or magnetic resonance angiography and response to intravenous thrombolytics in ischemic stroke
    Mair G [2017]
  • Antiactin-targeted immunoliposomes ameliorate tissue plasminogen activator-induced hemorrhage after focal embolic stroke
    Asahi M [2003]
  • Analysis of a two-domain binding site for the urokinase-type plasminogen activator-plasminogen activator inhibitor-1 complex in low-density-lipoprotein-receptor-related protein
    Andersen OM [2001]
  • An in vitro assay for sonothrombolysis based on the spectrophotometric measurement of clot thickness
    Wang Z [2017]
  • An animal model of cerebral infarction. Homologous blood clot emboli in rats
    Kudo M [1982]
  • Amplification of urokinase gene in prostate cancer
    Helenius MA [2001]
  • Amino-terminal fusion of epidermal growth factor 4, 5, 6 domains of human thrombomodulin on streptokinase confers anti-reocclusion characteristics along with plasmin-mediated clot specificity
  • Activity of plasmin and streptokinase-activator on substituted arginine and lysine esters
    Sherry S [1966]
  • Activity assessment of microbial fibrinolytic enzymes
    Kotb E [2013]
  • Access to and delivery of acute ischaemic stroke treatments : a survey of national scientific societies and stroke experts in 44 European countries
  • A technique for demonstrating fibrinolysis by cutaneous bacteria
  • A study of the fibrin plate assay of fibrinolytic agents. Optimal conditions, reproducibility and precision
    Jespersen J [1983]
  • A standard clot method for the assay of plasminogen activators, anti-activators, and plasmin
    Hawkey CM [1964]
  • A sensitive colorimetric assay for various proteases using naphthyl ester derivatives as substrates
    Niinobe M [1980]
  • A rat model of photothrombotic capsular infarct with a marked motor deficit: a behavioral, histologic, and microPET study
    Kim HS [2014]
  • A rat model of focal embolic cerebral ischemia
    Zhang RL [1997]
  • A rapid screening test for reduced fibrinolytic activity of plasma : streptokinase activated lysis time
    Gidron E [1978]
  • A rapid and sensitive 125I-fibrin solid-phase fibrinolytic assay for plasmin
    Moroz LA [1975]
  • A rapid and highly sensitive solid-phase radioassay for plasminogen activators
    Roche PC [1983]
  • A randomized trial of tenecteplase versus alteplase for acute ischemic stroke
    Parsons M [2012]
  • A proposed reference method for plasminogen activators that enables calculation of enzyme activities in SI units
    Longstaff C [2004]
  • A photothrombotic model of small early ischemic infarcts in the rat brain with histologic and MRI correlation
    Pevsner PH [2001]
  • A novel variant of t-PA resistant to plasminogen activator inhibitor-1; expression in CHO cells based on In Silico experiments
  • A novel mouse model of thromboembolic stroke
    Chen Y [2015]
  • A new recombinant thrombolytic and antithrombotic agent with higher fibrin affinity: a staphylokinase variant. I. In vitro study
    Szemraj J [2005]
  • A new rat model of thrombotic focal cerebral ischemia
    Zhang Z [1997]
  • A new global assay of coagulation and fibrinolysis
  • A new euglobulin clot lysis assay for global fibrinolysis
    Smith AA [2003]
  • A murine photothrombotic stroke model with an increased fibrin content and improved responses to tPA-lytic treatment
    Sun YY [2020]
  • A model of rat embolic cerebral infarction with a quantifiable, autologous arterial blood clot
    Shimamura N [2013]
  • A method for assessing clot lysis
    Howell M [1964]
  • A low molecular weight chymotrypsin-like novel fibrinolytic enzyme from Streptomyces sp. CS624
    Mander P [2011]
  • A long-half-life and fibrin-specific form of tissue plasminogen activator in rabbit models of embolic stroke and peripheral bleeding
    Thomas GR [1994]
  • A laboratory method for determination of overall haemostatic potential in plasma. I. Method design and preliminary results
    He S [1999]
  • A highly sensitive solid phase assay for plasminogen activators using 125I-fibrinogen
    Millar WT [1978]
  • A highly sensitive chromogenic microplate assay for quantification of rat and human plasminogen
    Kulseth MA [1993]
  • A high affinity interaction of plasminogen with fibrin is not essential for efficient activation by tissue plasminogen activator
    Kim PY [2012]
  • A faster-acting and more potent form of tissue plasminogen activator
    Keyt BA [1994]
  • A fast-acting, modular-structured staphylokinase fusion with kringle-1 from human plasminogen as the fibrin-targeting domain offers improved clot lysis efficacy
    Wu SC [2003]
  • A comparative analysis of the clotting and fibrinolytic activities of the snake venom(Bothrops atrox)from different geographical areas in Venezuela
    Salazar AM [2007]
  • A Novel Thrombolytic and Anticoagulant Serine Protease from Polychaeta, Diopatra sugokai
    김혜진 [2018]